Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1998 2
1999 2
2000 3
2001 1
2002 3
2003 3
2004 2
2005 6
2006 2
2007 5
2008 10
2009 14
2010 10
2011 7
2012 4
2013 8
2014 9
2015 9
2016 10
2017 4
2018 5
2019 4
2020 5
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

114 results
Results by year
Filters applied: . Clear all
Page 1
Lanreotide in metastatic enteropancreatic neuroendocrine tumors.
Caplin ME, Pavel M, Ćwikła JB, Phan AT, Raderer M, Sedláčková E, Cadiot G, Wolin EM, Capdevila J, Wall L, Rindi G, Langley A, Martinez S, Blumberg J, Ruszniewski P; CLARINET Investigators. Caplin ME, et al. N Engl J Med. 2014 Jul 17;371(3):224-33. doi: 10.1056/NEJMoa1316158. N Engl J Med. 2014. PMID: 25014687 Free article. Clinical Trial.
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.
Caplin ME, Baudin E, Ferolla P, Filosso P, Garcia-Yuste M, Lim E, Oberg K, Pelosi G, Perren A, Rossi RE, Travis WD; ENETS consensus conference participants. Caplin ME, et al. Ann Oncol. 2015 Aug;26(8):1604-20. doi: 10.1093/annonc/mdv041. Epub 2015 Feb 2. Ann Oncol. 2015. PMID: 25646366 Free article. Review.
Nutrition and pancreatic cancer.
Pericleous M, Rossi RE, Mandair D, Whyand T, Caplin ME. Pericleous M, et al. Among authors: caplin me. Anticancer Res. 2014 Jan;34(1):9-21. Anticancer Res. 2014. PMID: 24403441 Review.
Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study.
Caplin ME, Pavel M, Ćwikła JB, Phan AT, Raderer M, Sedláčková E, Cadiot G, Wolin EM, Capdevila J, Wall L, Rindi G, Langley A, Martinez S, Gomez-Panzani E, Ruszniewski P; CLARINET Investigators. Caplin ME, et al. Endocr Relat Cancer. 2016 Mar;23(3):191-9. doi: 10.1530/ERC-15-0490. Epub 2016 Jan 7. Endocr Relat Cancer. 2016. PMID: 26743120 Free PMC article. Clinical Trial.
Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors: An Expert Statement.
Davar J, Connolly HM, Caplin ME, Pavel M, Zacks J, Bhattacharyya S, Cuthbertson DJ, Dobson R, Grozinsky-Glasberg S, Steeds RP, Dreyfus G, Pellikka PA, Toumpanakis C. Davar J, et al. Among authors: caplin me. J Am Coll Cardiol. 2017 Mar 14;69(10):1288-1304. doi: 10.1016/j.jacc.2016.12.030. J Am Coll Cardiol. 2017. PMID: 28279296 Free article. Review.
Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome.
Kulke MH, Hörsch D, Caplin ME, Anthony LB, Bergsland E, Öberg K, Welin S, Warner RR, Lombard-Bohas C, Kunz PL, Grande E, Valle JW, Fleming D, Lapuerta P, Banks P, Jackson S, Zambrowicz B, Sands AT, Pavel M. Kulke MH, et al. Among authors: caplin me. J Clin Oncol. 2017 Jan;35(1):14-23. doi: 10.1200/JCO.2016.69.2780. Epub 2016 Oct 28. J Clin Oncol. 2017. PMID: 27918724 Clinical Trial.
Carcinoid Heart Disease: A Review.
Hayes AR, Davar J, Caplin ME. Hayes AR, et al. Among authors: caplin me. Endocrinol Metab Clin North Am. 2018 Sep;47(3):671-682. doi: 10.1016/j.ecl.2018.04.012. Endocrinol Metab Clin North Am. 2018. PMID: 30098723 Review.
114 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page